298 results found

Artificial Intelligence (AI) is playing an increasingly prominent role in the Irish healthcare system, particularly in areas such as medical imaging and diagnostics.

The long-awaited revision of the EU pharmaceutical legislation has reached a significant milestone: agreement has been secured at the trilogue stage between...

On 26 April 2023, the EU Commission made a proposal to overhaul the current EU pharmaceutical legislative regime, and introduce legislation that will create new rules for access to the market for medicinal products.

The risk of a serious and long-term impact on pharmaceutical supply chains as a result of COVID-19 is considered low at present. However, supply chain disruption may be nowhere as acutely felt, ...

While it may not be a healthcare professional's most exciting task, keeping good records is good professional practice and makes sense. Good healthcare records protect patients, staff and you, now and in the future.

Recent legislation provides that a family member could receive free legal aid or advice at an inquest where it is in the public interest.

Employers not complying with their ESG obligations face regulatory, capital, and talent retention challenges. Our survey shows that only 17% of Irish employers are aware of these obligations.

Pharmacists will be all too aware of the Pharmacy Regulator’s recent Guidance on the safe supply of non-prescription medicines containing codeine which took effect on 1st August.

Following an intensive period of deliberation and consultation with interested parties, the Group concluded that the current system of awarding damages for future pecuniary losses - the lump sum award - is inadequate and inappropriate.

The President of the High Court has issued two new practice directions (HC131 and HC 132) (the "Directions") to apply to clinical negligence claims. They will come into force on 28 April 2025.

Practice Direction HC131 commencing on 28 April provides a new procedure for the application for trial dates in clinical negligence actions.

The Government recently approved the creation of new law which will provide an alternative to large, once off awards in cases involving catastrophic injuries.

The medical device landscape in the EU underwent significant regulatory developments over the past few years. 2024 is going to be another year of change for the sector.

The following Bills are currently passing through the Dáíl and Seanad stages and are expected to be enacted shortly...

The Council of the EU has adopted the most comprehensive reform of EU pharmaceutical legislation in over 20 years, fundamentally reshaping regulatory protection mechanisms, market exclusivity periods, and incentive structures for pharmaceutical companies. These reforms balance patient access to medicines with creating a more competitive and innovation-friendly environment, addressing antimicrobial resistance, medicine supply challenges, and the early availability of generic alternatives.

In a joint press conference on 16 December, Commissioners Várhelyi (Commissioner for Health and Animal Welfare) and Dombrovskis (Commissioner for Economy and Productivity...

In this context, it is timely to recall what the IPHA Agreement covers and its importance to industry.